Skip to main content
. 2023 Jun 1;6(8):e202301902. doi: 10.26508/lsa.202301902

Table 2.

Serum data of miR-33fl/fl KI and Alb-Cre/miR-33bfl/fl KI mice fed a 45% HFD.

miR-33bfl/fl KI Alb-Cre/miR-33bfl/fl KI
TP (g/dl) 4.33 ± 0.20 4.43 ± 0.08
ALB (g/dl) 2.73 ± 0.08 2.77 ± 0.04
AST (IU/l) 105.8 ± 27.4 45.7 ± 2.6 *
ALT (IU/l) 63.3 ± 16.2 26.7 ± 4.9 *
ALP (IU/l) 237.5 ± 51.3 213.1 ± 14.5
LDH (IU/l) 663.5 ± 100.1 420.4 ± 55.6 *
T-BIL (mg/dl) 0.241 ± 0.103 0.075 ± 0.007
TBA (μmol/l) 29.8 ± 20.0 1.43 ± 0.20
T-Cho (mg/dl) 71.8 ± 12.8 139.1 ± 9.2 **
LDL-C (mg/dl) 5.5 ± 0.7 3.2 ± 1.3 *
HDL-C (mg/dl) 38.8 ± 7.9 64.6 ± 8.0 **
TG (mg/dl) 25.1 ± 4.0 23.9 ± 4.2
NEFA (μEq/l) 428.0 ± 41.2 433.6 ± 30.8

Male mice were fed a 45% HFD from the age of 8 wk for 12 wk. Values are the mean ± S.E.M., n = 6, 7 each; *P < 0.05 and **P < 0.01, unpaired t test.